E-mails to Nudge Safer and Better-Informed Prescribing of Risky Drugs

NAActive, not recruitingINTERVENTIONAL
Enrollment

7,872

Participants

Timeline

Start Date

July 17, 2024

Primary Completion Date

September 14, 2024

Study Completion Date

December 31, 2025

Conditions
Opioid PrescribingPrescription Drug Misuse
Interventions
BEHAVIORAL

PDMP Legal Mandate E-mail

E-mails highlighting the state's legal requirements to use the PDMP. There will be one initial email and one follow-up email one month later.

BEHAVIORAL

PDMP Clinical Benefit E-mail

E-mails highlighting the clinical benefits of having access to the PDMP and checking the PDMP before prescribing opioids. There will be one initial email and one follow-up email one month later.

Trial Locations (1)

10032

Columbia University Irving Medical Center, New York

All Listed Sponsors
collaborator

University of Southern California

OTHER

collaborator

Bowdoin College

OTHER

collaborator

Abdul Latif Jameel Poverty Action Lab

OTHER

collaborator

Minnesota Management and Budget

UNKNOWN

collaborator

Minnesota Board of Pharmacy

OTHER

lead

Columbia University

OTHER

NCT06443385 - E-mails to Nudge Safer and Better-Informed Prescribing of Risky Drugs | Biotech Hunter | Biotech Hunter